Wednesday, April 06, 2022 12:30:37 PM
Agree, Manufacturing facilities all over the filings:
Here's one:
"The company has signed a definitive agreement with one of Southern California based pharmaceutical manufacturing facility to acquire them."
https://www.otcmarkets.com/otcapi/company/financial-report/324753/content
The Company’s strategic manufacturing facility in an area considered one of the safest and perfect for pharmaceutical operations. The facility is approximately 5,500 square feet. In February 2009, SHMN’s manufacturing facility was licensed by the India FDA. The license indicates compliance with Current Good Manufacturing Practice (CGMP) Regulations: Division of Manufacturing and Product Quality and compliant with World Health Organization (WHO) regulations and FDA.
Investments in real estate or interest in real estate
The Issuer does not intend to invest in Real Estate outside of ownership in its executive offices or manufacturing facilities.
The Company is headquartered in Chino Hills, California, U.S.A. and the Company’s strategic manufacturing facility is located in Southern California, in an area considered one of the safest and perfect for pharmaceutical operations. The facility is approximately 5,500 square feet.
>>>>>>>>>>>>>>>>>
Agree, tiny, tiny, International Pharma Company (tiny)...that drop ships from these small facilities via Private label. And, they have also signed an agreement to Purchase another tiny tiny facility (in the scheme of things). Did I say tiny?
>>>>>>>>>>>
Summation? Revenues, and we're at .0016. (Tiny)
But (Big) Green Candle Coming, right? Agreed.
hl shmn
Here's one:
"The company has signed a definitive agreement with one of Southern California based pharmaceutical manufacturing facility to acquire them."
https://www.otcmarkets.com/otcapi/company/financial-report/324753/content
The Company’s strategic manufacturing facility in an area considered one of the safest and perfect for pharmaceutical operations. The facility is approximately 5,500 square feet. In February 2009, SHMN’s manufacturing facility was licensed by the India FDA. The license indicates compliance with Current Good Manufacturing Practice (CGMP) Regulations: Division of Manufacturing and Product Quality and compliant with World Health Organization (WHO) regulations and FDA.
Investments in real estate or interest in real estate
The Issuer does not intend to invest in Real Estate outside of ownership in its executive offices or manufacturing facilities.
The Company is headquartered in Chino Hills, California, U.S.A. and the Company’s strategic manufacturing facility is located in Southern California, in an area considered one of the safest and perfect for pharmaceutical operations. The facility is approximately 5,500 square feet.
>>>>>>>>>>>>>>>>>
Agree, tiny, tiny, International Pharma Company (tiny)...that drop ships from these small facilities via Private label. And, they have also signed an agreement to Purchase another tiny tiny facility (in the scheme of things). Did I say tiny?
>>>>>>>>>>>
Summation? Revenues, and we're at .0016. (Tiny)
But (Big) Green Candle Coming, right? Agreed.
hl shmn
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
